Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
Bill of Health
JANUARY 6, 2022
The National Institutes of Health (NIH) is currently embroiled in a dispute over the ownership of patent rights to Moderna’s flagship mRNA COVID-19 vaccine (mRNA-1273). If so, NIH, their employer, would be a co-owner of the vaccine technology and could, in theory, make it more broadly available around the world.
Let's personalize your content